Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
A first exon-encoded domain of E1A sufficient for posttranslational modification, nuclear-localization, and induction of adenovirus E3 promoter expression in Xenopus oocytes.
Richter JD, Young P, Jones NC, Krippl B, Rosenberg M, Ferguson B.
???displayArticle.abstract???
The purified Escherichia coli-expressed human subgroup C adenovirus E1A 13S mRNA product induces expression from the adenovirus type 5 E3 promoter when injected into Xenopus oocytes. In the present communication, the E. coli-expressed E1A 13S and 12S mRNA products are shown to undergo a posttranslational modification in microinjected Xenopus oocytes, which causes a 2- to 4-kDa increase in apparent molecular size, identical to that occurring in HeLa cells expressing the E1A gene. The E. coli-expressed E1A proteins are similarly modified in vitro in a soluble rabbit reticulocyte lysate. The modified form of the E1A proteins preferentially localizes to the oocytenucleus following cytoplasmic microinjection. The use of various deleted forms of E1A protein synthesized in E. coli shows that a first exon-encoded domain of E1A, residing between amino acid residues 23 and 120, is sufficient for the posttranslational modification and nuclear localization of E1A and also for the trans-activation of the E3 promoter by E1A in Xenopus oocytes. These results suggest that the posttranslational modification of E1A protein may be important for its function.
Alitalo,
Identification of nuclear proteins encoded by viral and cellular myc oncogenes.
, Pubmed
Alitalo,
Identification of nuclear proteins encoded by viral and cellular myc oncogenes.
,
Pubmed Bos,
Deletion mutants of region E1a of AD12 E1 plasmids: effect on oncogenic transformation.
1983,
Pubmed Curran,
Viral and cellular fos proteins: a comparative analysis.
1984,
Pubmed Darveau,
Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5' untranslated region.
1985,
Pubmed Downey,
Peptide maps and N-terminal sequences of polypeptides from early region 1A of human adenovirus 5.
1984,
Pubmed Esche,
Proteins and messenger RNAs of the transforming region of wild-type and mutant adenoviruses.
1980,
Pubmed Feldman,
Localization of the adenovirus E1Aa protein, a positive-acting transcriptional factor, in infected cells infected cells.
1983,
Pubmed Ferguson,
Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional.
1984,
Pubmed
,
Xenbase Ferguson,
E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA.
1985,
Pubmed Green,
Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2.
1979,
Pubmed Halbert,
Tryptic and chymotryptic methionine peptide analysis of the in vitro translation products specified by the transforming region of adenovirus type 2.
1982,
Pubmed Halbert,
In vitro translation products specified by the transforming region of adenovirus type 2.
1979,
Pubmed Hann,
Proteins encoded by v-myc and c-myc oncogenes: identification and localization in acute leukemia virus transformants and bursal lymphoma cell lines.
1983,
Pubmed Jochemsen,
The first exon of region E1a genes of adenoviruses 5 and 12 encodes a separate functional protein domain.
1984,
Pubmed Jones,
Regulation of adenovirus transcription by an E1a gene in microinjected Xenopus laevis oocytes.
1983,
Pubmed
,
Xenbase Krippl,
Functions of purified E1A protein microinjected into mammalian cells.
1984,
Pubmed Krippl,
Mapping of functional domains in adenovirus E1A proteins.
1985,
Pubmed Lewis,
Organization and expression of the left third of the genome of adenovirus.
1980,
Pubmed Lupker,
In vitro synthesis of adenovirus type 5 T antigens. I. Translation of early region 1-specific rna from lytically infected cells.
1981,
Pubmed Matlashewski,
Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
1984,
Pubmed Mattaj,
Nuclear segregation of U2 snRNA requires binding of specific snRNP proteins.
1985,
Pubmed
,
Xenbase Mott,
Maximizing gene expression from plasmid vectors containing the lambda PL promoter: strategies for overproducing transcription termination factor rho.
1985,
Pubmed Paine,
Nuclear envelope permeability.
1975,
Pubmed Perricaudet,
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.
1979,
Pubmed Persson,
Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation.
1984,
Pubmed Rowe,
Characterization of human adenovirus type 5 early region 1A polypeptides using antitumor sera and an antiserum specific for the carboxy terminus.
1983,
Pubmed Smart,
Adenovirus type 2 early proteins: assignment of the early region 1A proteins synthesized in vivo and in vitro to specific mRNAs.
1981,
Pubmed Solnick,
Transformation-deficient adenovirus mutant defective in expression of region 1A but not region 1B.
1982,
Pubmed Velcich,
Adenovirus E1a proteins repress transcription from the SV40 early promoter.
1985,
Pubmed Weeks,
E1A control of gene expression is mediated by sequences 5' to the transcriptional starts of the early viral genes.
1983,
Pubmed Yee,
Identification of human adenovirus early region 1 products by using antisera against synthetic peptides corresponding to the predicted carboxy termini.
1983,
Pubmed
